Risk factors

Kestra Medical Technologies (KMTS) risk factors

Item 1A of every Kestra Medical Technologies, Ltd. 10-K on file, and what changed from one year to the next.

Open KMTS in Gloomberb →
  • FY2026 10-K risk factors

    81 risks, 80 new, 91 dropped, 1 reworded since the prior year. IPO and secondary offering produced $215.8 million of net proceeds and increased interest income by $5.2 million.

    Filed Jul 14, 2026
  • FY2025 10-K risk factors

    92 risks. Kestra Medical Technologies faces intense competition in the wearable cardioverter defibrillator market dominated by ZOLL's LifeVest and new adhesive-based alternatives.

    Filed Jul 17, 2025